
Setglim M 2mg/500mg Tablet SR
Marketer
Biospark Pharmaceuticals And Laboratories Pvt Ltd
Salt Composition
Glimepiride (2mg) + Metformin (500mg)
Overview Setglim M 2mg/500mg Tablet SR
Diabexe Duo 2mg/500mg extended-release tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by managing blood glucose levels. Diabexe Duo should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can lead to elevated glucose levels, increasing the risk of complications such as kidney impairment, vision loss, neuropathy, and limb amputation. This medication forms part of a comprehensive diabetes management plan including dietary adjustments, regular physical activity, and weight management as recommended by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by symptoms like sweating, lightheadedness, headache, and tremors. Learn to recognize and manage these symptoms, ensuring regular meals and carrying a rapid-acting glucose source like candy or juice. Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Additional potential side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may also occur. This medication is contraindicated in individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart conditions should be disclosed to your physician before commencing treatment. Consult your doctor before using Diabexe Duo if pregnant or breastfeeding. Regular blood glucose monitoring and periodic blood tests to assess blood cell counts and liver function are recommended.
Primary Ingredients of Setglim M 2mg/500mg Tablet SR
No information provided. Please provide the text you wish me to rephrase.
Uses of Setglim M 2mg/500mg Tablet SR
Managing type 2 diabetes
Major Benefits of Setglim M 2mg/500mg Tablet SR:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Setglim M 2mg/500mg Tablet SR with a meal.
Common Side effects of Setglim M 2mg/500mg Tablet SR:
- Headache
- Hypoglycemia (low blood glucose level)
- Nausea
- Diarrhea
How to use Setglim M 2mg/500mg Tablet SR:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Setglim M 2mg/500mg Sustained-Release tablets should be taken with a meal.
How Setglim M 2mg/500mg Tablet SR works:
Setglim M 2mg/500mg extended-release tablets contain glimepiride and metformin, two medications used to manage diabetes. Glimepiride, a sulfonylurea, stimulates the pancreas to release more insulin, thus reducing blood sugar. Metformin, a biguanide, acts through a three-pronged approach: decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol concurrently with Setglim M 2mg/500mg SR tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Setglim M 2mg/500mg SR tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescription. Seek medical advice.
Breast feedingUNSAFE
Continued breastfeeding while taking Setglim M 2mg/500mg SR tablets is contraindicated due to the potential for infant harm from the medication's components.
DrivingCAUTION
Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.
KidneyCAUTION
Exercise caution when administering Setglim M 2mg/500mg SR tablets to individuals with impaired renal function; dosage modification may be necessary. Consult a physician before use. Setglim M 2mg/500mg SR tablets are contraindicated in patients exhibiting severe kidney disease. Routine monitoring of kidney function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Setglim M 2mg/500mg SR tablets cautiously, potentially requiring dosage modification. Physician consultation is advised. For those with mild to moderate liver disease, initiation should be at a low dose; the medication is contraindicated in severe liver disease.
What if you forget to take Setglim M 2mg/500mg Tablet SR :
Should you forget a Setglim M 2mg/500mg SR Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Setglim M 2mg/500mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Treatment |
